Dennis Podlesak

Investing Profile

Sweet spot: $1.5M Range: $100K–$5M Fund: $163.6M

Domain Associates thesis

FOUNDED IN 1985 FOUNDED IN 1985 FOUNDED IN 1985 FOUNDED IN 1985 INVESTMENT ADVISORS TO THE FIRST VC FUND DEDICATED TO BIOTECH INVESTMENT MANAGER OF 9 SUBSEQUENT BIOTECH VC FUNDS $2.8 Billion assets managed VC funding of 194 biopharm, device and diagnostic companies 90 IPOs 110 M&A events $190 Billion market cap of funded companies Click for More Info and Portfolio Team Members James Blair, Partner Brian Dovey, Partner (In Memorium 2023) Brian Halak, Partner Kim Kamdar, Partner Jesse Treu, Partner Emeritus Nicole Vitullo, Partner Kathleen Schoemaker, Partner and CFO (In Memorium 2016) Lisa Krae

Sector and stage focus

  • Seed: Pharmaceuticals, Health IT, Digital Health, Health & Hospital Services
  • Series B: Pharmaceuticals, Health & Hospital Services, Digital Health, Health IT
  • Series A: Pharmaceuticals, Health IT, Health & Hospital Services, Digital Health
  • general: New York City

Recent investments by Dennis Podlesak

Dennis Podlesak has 1 named past investments in the public record. The most recent:

Company Stage Date Round size
Syndax Pharmaceuticals Series C Aug 2015 $80M

Frequent co-investors

Dennis Podlesak has co-invested with: Kim P. Kamdar, Steven St. Peter.

Is Dennis Podlesak a fit for your round?

Upload your pitch deck and see whether Dennis Podlesak appears in your top 20 matches.

Find investors for your deck